[Clinical value of entecavir in improving chronic hepatitis B with insulin resistance and hepatogenic diabetes]

Zhonghua Gan Zang Bing Za Zhi. 2018 Aug 20;26(8):618-620. doi: 10.3760/cma.j.issn.1007-3418.2018.08.011.

[Article in Chinese]

Authors

J Zhou¹, H Z Wang, Y C Li, W Y Hu, C X Li, C J Chen, L L Zhang

Affiliation

¹ Department of Infectious Disease, The First People's Hospital of Yongkang, Zhejiang 321300, China.

PMID: 30317795
DOI: 10.3760/cma.j.issn.1007-3418.2018.08.011

No abstract available

Keywords: Entecavir; Hepatitis B, chronic; Hepatogenic diabetes; Insulin resistance.

Grants and funding

201513/Yongkang Science and Technology Plan Projects